Combined Therapy with Anthracyclines and GnRH Analogues for Breast Cancer: Impact on Ischemic Heart Disease

Author:

Bergami Maria1ORCID,Manfrini Olivia1,Cenko Edina1ORCID,Bugiardini Raffaele1ORCID

Affiliation:

1. Laboratory of Epidemiological and Clinical Cardiology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy

Abstract

The combination of classic chemotherapy agents like anthracyclines with novel targeted medications has had a positive impact on women’s survival from breast cancer. GnRH analogues are primarily employed to temporarily suppress ovarian function in premenopausal women with hormone-receptor-positive (HR+) breast cancer. Despite their benefits, the true degree of their collateral effects has been widely understudied, especially when it comes to ischemic heart disease. This review aims at summarizing the current state of the art on this issue, with particular focus on the risk for cardiotoxicity associated with the combined use of GnRH analogues and anthracyclines.

Publisher

MDPI AG

Subject

General Medicine

Reference76 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023

2. Cancer Statistics Center (2023, August 23). Breast at a Glance. Available online: https://cancerstatisticscenter.cancer.org/?_ga=2.95677403.676965058.1694424103-605706838.1694424103&_gl=1*i5be81*_ga*NjA1NzA2ODM4LjE2OTQ0MjQxMDM.*_ga_12CJLLFFQT*MTY5NDQyNDEwMy4xLjEuMTY5NDQyNDQ2Mi4wLjAuMA.#!/cancer-site/Breast.

3. (2023, August 23). Breast Cancer in Young Women, Available online: https://www.cdc.gov/cancer/breast/young_women/bringyourbrave/breast_cancer_young_women/index.htm.

4. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†;Cardoso;Ann. Oncol.,2019

5. (2023, June 14). Early and Locally Advanced Breast Cancer: Diagnosis and Management, Available online: https://www.ncbi.nlm.nih.gov/books/NBK519155/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3